Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review
Microorganisms · 15.11.2024 · 12 (11) · 2320
DOI: 10.3390/microorganisms12112320 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 15.11.2024. Verfasst von Ana P Ruiz-Lievano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina Humana, Universidad Autónoma de Chiapas, Tuxtla Gutiérrez 29050, Chiapas, Mexico. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Fondo Semilla” from Universidad Autónoma de Guadalajara.
Abstract (Originalsprache)
Community-acquired urinary tract infections account for 15% of all outpatient use of antibiotics, and women are primarily affected; the major causative microorganism is uropathogenic Escherichia coli (E. coli). Treatment is indicated for cystitis and pyelonephritis and includes B-lactams (amoxicillin-clavulanic acid or third-generation cephalosporins), fluoroquinolones (ciprofloxacin or levofloxacin), nitrofurantoin, fosfomycin, and trimethoprim–sulfamethoxazole. Resistance to antibiotic treatment is of concern; several mechanisms have been associated with the acquisition of genes that confer antimicrobial resistance to fluoroquinolones, which are often associated with other patterns of resistance, especially in extended-spectrum beta-lactamase (ESBL) producers. Several studies have addressed the prevalence of uropathogens producing ESBLs, but only a few have focused on fluoroquinolone resistance, and, to our knowledge, none have addressed the prevalence of phylotypes or genes responsible for antimicrobial resistance to fluoroquinolones. The focus of the present review was to analyze recently published papers that described the E. coli phylotype causing community-acquired UTIs in association with fluoroquinolone resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Medicina Humana, Universidad Autónoma de Chiapas, Tuxtla Gutiérrez 29050, Chiapas, Mexico.
- Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla 72410, Puebla, Mexico.
- Unidad Académica Ciencias de la Salud, Universidad Autónoma de Guadalajara, Zapopan 45129, Jalisco, Mexico.
ORCID-Profile: Ana P Ruiz-Lievano, Maria G Zavala-Cerna
Förderung
- “Fondo Semilla” from Universidad Autónoma de Guadalajara
Zitieren
APA
Ruiz-Lievano, A. P., Cervantes-Flores, F., Nava-Torres, A., Carbajal-Morales, P. J., Villaseñor-Garcia, L. F., & Zavala-Cerna, M. G. (2024). Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review. Microorganisms, 12(11), 2320. https://doi.org/10.3390/microorganisms12112320
Vancouver
Ruiz-Lievano AP, Cervantes-Flores F, Nava-Torres A, Carbajal-Morales PJ, Villaseñor-Garcia LF, Zavala-Cerna MG. Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review. Microorganisms. 2024;12(11):2320. doi:10.3390/microorganisms12112320
BibTeX
@article{RuizLievano2024,
author = {Ruiz-Lievano, Ana P and Cervantes-Flores, Fernando and Nava-Torres, Alessandro and Carbajal-Morales, Paulo J and Villaseñor-Garcia, Luisa F and Zavala-Cerna, Maria G},
title = {Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {11},
pages = {2320},
doi = {10.3390/microorganisms12112320}
}
EUVIMED